- Exelixis to Present at the William Blair 44th Annual Growth Stock Conference
- Exelixis Announces Settlement of CABOMETYX® (cabozantinib) Patent Litigation with Cipla Limited and Cipla USA
- Exelixis to Webcast Fireside Chats as Part of Investor Conferences in May
- Exelixis Announces First Quarter 2024 Financial Results and Provides Corporate Update
- Exelixis to Release First Quarter 2024 Financial Results on Tuesday, April 30, 2024
More ▼
Key statistics
On Tuesday, Exelixis Inc (EXEL:NSQ) closed at 22.15, -9.00% below its 52-week high of 24.34, set on Jan 02, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 22.18 |
---|---|
High | 22.26 |
Low | 22.05 |
Bid | 21.20 |
Offer | 22.83 |
Previous close | 22.15 |
Average volume | 2.04m |
---|---|
Shares outstanding | 291.29m |
Free float | 284.89m |
P/E (TTM) | 34.26 |
Market cap | 6.45bn USD |
EPS (TTM) | 0.6466 USD |
Data delayed at least 15 minutes, as of Jul 02 2024 21:00 BST.
More ▼